Opinion|Videos|August 23, 2024
Uveal Melanoma Prognosis and Risk Stratification
Author(s)Nathan L. Scott, M.D., Melody Burchett
Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification
Advertisement
Episodes in this series
Video content above is prompted by the following:
- For patients diagnosed with uveal melanoma, what is the prognosis and the risk of recurrence?
- Briefly discuss the risk class levels and what strategies are implanted for monitoring.
- When uveal melanoma spreads, what are the common sites of metastasis?
- What are some concerns that patients have?
Advertisement
Related to this article
See how FDA-approved lymphoma treatments have changed over 5 years — what's new, who it's helped, and what's still to come.
Kazia Therapeutics CEO Dr. John Friend discussed how paxalisib is being studied in HR-positive, HER2-negative breast cancer, why researchers are focusing on treatment resistance and what the ongoing clinical trial could show for patients.
An expert discusses August's FDA approvals for myeloma, polycythemia vera and essential thrombocythemia, plus first-line myeloma care and MRD testing.
Patients with colorectal cancer who walked more had less fatigue and better quality of life, regardless of how active they were at diagnosis.
CURE spoke with Oncology Aesthetics & Wellness founder, Deborah A. McDowell, about hair preservation before, during and after cancer treatment.
A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer.
A wife reflects on her husband’s cancer treatment, finding comfort, hope and connection in their simple ritual of sharing bagels before each treatment.
Survivors and experts share what to do before your first chemo infusion, from scalp cooling and saving your hair to skin care and building a support team.
Advertisement
Advertisement
Trending on CURE
1
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
2
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
3
10 Things That Got Me Through Treatment feat. Sally Kalksma
4
How Paxalisib Targets Treatment Resistance in Breast Cancer
5